In:
Cancer, Wiley, Vol. 126, No. 3 ( 2020-02), p. 575-582
Abstract:
In the current study, the authors have created a novel risk scoring system that appears to be significantly associated with survival in patients with cancer who are treated with immunotherapy in phase 1 clinical trials. This study is important for practicing oncologists because the authors have provided clinically relevant cutoff values for subcutaneous and intermuscular fat indices that may be used to risk stratify patients who are treated with immunotherapy.
Type of Medium:
Online Resource
ISSN:
0008-543X
,
1097-0142
Language:
English
Publisher:
Wiley
Publication Date:
2020
detail.hit.zdb_id:
1479932-7
detail.hit.zdb_id:
2599218-1
detail.hit.zdb_id:
2594979-2
detail.hit.zdb_id:
1429-1